EVP-6124

EnVivo Pharma reports positive phase II b trial results from EVP-6124 in Alzheimer’s disease
Pharmabiz
Sat, 07/21/12 - 12:02 pm
EnVivo
EVP-6124
Alzheimer's disease
New EnVivo drug for Alzheimer's symptom relief shows promise
Reuters
Wed, 07/18/12 - 12:54 pm
EnVivo
Alzheimer's disease
EVP-6124